HK1000906A1 - Compositions for nasal administration of desmopressin - Google Patents

Compositions for nasal administration of desmopressin

Info

Publication number
HK1000906A1
HK1000906A1 HK97102555A HK97102555A HK1000906A1 HK 1000906 A1 HK1000906 A1 HK 1000906A1 HK 97102555 A HK97102555 A HK 97102555A HK 97102555 A HK97102555 A HK 97102555A HK 1000906 A1 HK1000906 A1 HK 1000906A1
Authority
HK
Hong Kong
Prior art keywords
composition
desmopressin
nasal administration
container
assembly
Prior art date
Application number
HK97102555A
Other languages
English (en)
Inventor
Alan Harris
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of HK1000906A1 publication Critical patent/HK1000906A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Otolaryngology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
HK97102555A 1993-06-29 1997-12-22 Compositions for nasal administration of desmopressin HK1000906A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8489493A 1993-06-29 1993-06-29
PCT/SE1994/000623 WO1995001183A1 (fr) 1993-06-29 1994-06-22 Compositions permettant l'administration par voie nasale de desmopressine

Publications (1)

Publication Number Publication Date
HK1000906A1 true HK1000906A1 (en) 2002-03-08

Family

ID=22187889

Family Applications (1)

Application Number Title Priority Date Filing Date
HK97102555A HK1000906A1 (en) 1993-06-29 1997-12-22 Compositions for nasal administration of desmopressin

Country Status (20)

Country Link
US (1) US5498598A (fr)
EP (1) EP0708657B1 (fr)
JP (1) JPH09502425A (fr)
KR (1) KR100193104B1 (fr)
CN (1) CN1101701C (fr)
AT (1) ATE203412T1 (fr)
CA (1) CA2166312C (fr)
CZ (1) CZ282456B6 (fr)
DE (1) DE69427820T2 (fr)
DK (1) DK0708657T3 (fr)
ES (1) ES2158898T3 (fr)
GR (1) GR3036936T3 (fr)
HK (1) HK1000906A1 (fr)
HU (1) HU221617B1 (fr)
NZ (1) NZ268442A (fr)
PL (1) PL176317B1 (fr)
PT (1) PT708657E (fr)
RU (1) RU2135204C1 (fr)
SK (1) SK282844B6 (fr)
WO (1) WO1995001183A1 (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0710243B1 (fr) * 1993-06-29 2000-06-14 Ferring B.V. Synthese de peptides cycliques
US5482931A (en) * 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
US5674850A (en) * 1993-12-23 1997-10-07 Ferring Ab High purity desmopressin produced in large single batches
SE9400918L (sv) * 1994-03-18 1995-09-19 Anne Fjellstad Paulsen Stabiliserad komposition för oral administrering av peptider
US5763398A (en) * 1996-06-20 1998-06-09 Ferring B.V. Nasal administration of desmopressin
US5916582A (en) * 1996-07-03 1999-06-29 Alza Corporation Aqueous formulations of peptides
GB9614235D0 (en) * 1996-07-06 1996-09-04 Danbiosyst Uk Composition for enhanced uptake of polar drugs from mucosal surfaces
US5922680A (en) * 1996-10-23 1999-07-13 Ferring, B.V. Stabilized composition for oral administration of peptides
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
JP2001233787A (ja) 2000-02-04 2001-08-28 Patents Exploitation Co Bv 小・中サイズのペプチド含有薬学的組成物
US6641799B2 (en) 2002-04-03 2003-11-04 Nos Spray, Inc. Nasal spray for decongesting nasal passages
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
WO2003097080A1 (fr) * 2002-05-15 2003-11-27 Sun Pharmaceutical Industries Limited Composition aqueuse stable de peptide
EP1530967B1 (fr) * 2003-11-13 2006-05-03 Ferring B.V. Emballage Blister et forme de dosage solide comprenant de la desmopressine
SE528446C2 (sv) * 2006-03-02 2006-11-14 Ferring Int Ct Sa Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse
KR101522747B1 (ko) 2007-08-06 2015-05-26 알레간 인코포레이티드 데스모프레신 약물 전달을 위한 방법 및 장치
CN101372504B (zh) * 2007-08-22 2011-05-18 深圳翰宇药业股份有限公司 一种纯化去氨加压素的方法
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
LT2712622T (lt) 2008-05-21 2016-09-26 Ferring B.V. Burnoje disperguojamas desmopresinas, skirtas nikturijos netrikdomo miego pirminio periodo pailginimui
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
WO2010075327A1 (fr) * 2008-12-22 2010-07-01 Serenity Pharmaceuticals Corporation Composition de desmopressine
EP2381923B2 (fr) * 2008-12-22 2023-06-07 Acerus Pharmaceuticals USA, LLC Administration intranasale de desmopressine
AU2015261630B2 (en) * 2008-12-22 2017-09-14 Acerus Pharmaceuticals USA, LLC Intranasal desmopressin administration
PT3679941T (pt) * 2009-06-18 2022-11-10 Serenity Pharmaceuticals Llc Administração segura de desmopressina
CN102440957B (zh) * 2011-12-16 2013-09-25 深圳市健元医药科技有限公司 醋酸特利加压素鼻腔喷雾剂及其制备方法
AU2015370666B2 (en) 2014-12-22 2020-09-03 Arovella Therapeutics Limited Prevention and treatment of metastatic disease in thrombocytotic cancer patients
WO2024105521A1 (fr) * 2022-11-17 2024-05-23 Shilpa Medicare Limited Composition pharmaceutique peptidique stable

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4271068A (en) * 1968-05-10 1981-06-02 Ciba-Geigy Corporation Process for the manufacture of cystine-containing peptides
CH517705A (de) * 1969-12-16 1972-01-15 Ciba Geigy Ag Verfahren zur Herstellung von Cystin-haltigen Peptiden
US3929758A (en) * 1974-09-12 1975-12-30 Armour Pharma Cyclization of cysteine-containing peptides
US4033940A (en) * 1975-11-12 1977-07-05 Armour Pharmaceutical Company Cyclization of peptides
US4093610A (en) * 1977-01-31 1978-06-06 American Home Products Corporation Process for producing triglycyl-lysine vasopressin and intermediates therefor
US4216141A (en) * 1978-07-19 1980-08-05 The Salk Institute For Biological Studies Method for cyclization of peptides
DE2923787A1 (de) * 1979-06-12 1980-12-18 Max Planck Gesellschaft Verfahren zur selektiven bildung von disulfidbruecken in polypeptiden und die dabei erhaltenen produkte als wirkstoffe enthaltende arzneimittel
IE56021B1 (en) * 1982-10-13 1991-03-27 Akzo Nv Peptides
JPS61194034A (ja) * 1985-02-25 1986-08-28 Teijin Ltd 経鼻投与用粉末状組成物
EP0300036A4 (fr) * 1987-01-30 1989-06-14 Biomed Res Consultants Ltd Compositions pharmaceutiques a base de vasopressine.
US5066716A (en) * 1988-12-13 1991-11-19 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Synthesis of chloroacetyl and bromoacetyl modified peptides for the preparation of synthetic peptide polymers, conjugated peptides, and cyclic peptides
ATE108326T1 (de) * 1989-01-30 1994-07-15 Corint Ltd Wässerige desmopressin-cmc enthaltende arzneizubereitung.
EP0432431B1 (fr) * 1989-11-16 1993-06-16 PHIDEA S.p.A. Composition liquide pharmaceutique pour application nasale contenant un polypeptide comme ingrédient actif

Also Published As

Publication number Publication date
ATE203412T1 (de) 2001-08-15
DK0708657T3 (da) 2001-10-15
HU9503833D0 (en) 1996-02-28
KR100193104B1 (ko) 1999-06-15
CZ339095A3 (en) 1996-09-11
SK282844B6 (sk) 2002-12-03
DE69427820T2 (de) 2001-11-08
RU2135204C1 (ru) 1999-08-27
PL176317B1 (pl) 1999-05-31
EP0708657A1 (fr) 1996-05-01
WO1995001183A1 (fr) 1995-01-12
CA2166312C (fr) 2002-04-23
NZ268442A (en) 1996-09-25
US5498598A (en) 1996-03-12
CN1101701C (zh) 2003-02-19
KR960703339A (ko) 1996-08-17
CA2166312A1 (fr) 1995-01-12
HU221617B1 (hu) 2002-12-28
DE69427820D1 (de) 2001-08-30
SK165095A3 (en) 1996-11-06
GR3036936T3 (en) 2002-01-31
EP0708657B1 (fr) 2001-07-25
HUT73776A (en) 1996-09-30
JPH09502425A (ja) 1997-03-11
PT708657E (pt) 2001-11-30
CZ282456B6 (cs) 1997-07-16
PL312204A1 (en) 1996-04-01
ES2158898T3 (es) 2001-09-16
CN1126439A (zh) 1996-07-10

Similar Documents

Publication Publication Date Title
GR3036936T3 (en) Compositions for nasal administration of desmopressin
HU9602720D0 (en) Improved anti-dandruff shampoo
HUT73775A (en) Stabilized pharmaceutical peptide compositions
MD1699F2 (ro) Compoziţie apoasă a hormonului somatotrop uman şi procedeu de prevenire a denaturării ei
AU3183389A (en) Human relaxin formulation
HUT64567A (en) Method for producing new cyclosporines and preparations containing said compounds as active agent
CA2016659A1 (fr) Compose stabilise contenant un facteur de croissance epidermique
CA2203033A1 (fr) Composes et compositions pour l'administration d'agents actifs
HUT75089A (en) Compositions containing hyaluronic acid or it's derivatives and pharmaceutical active agent
CA2308513A1 (fr) Procede et composition permettant d'administrer du zinc ionique a une membrane nasale
CA2113995A1 (fr) Utilisation d'acide gentisique ou d'alcool gentisique pour la stabilisation de peptides et de proteines radiomarques
GR1003011B (el) Νεα συνθεση
MX9701170A (es) Composicion antitranspirante en aerosol con poco propulsor.
HU9501801D0 (en) Lactame-compounds as pharmaceutical active component
YU40398A (sh) Kompozicija nazalnog spreja za davanje sredstva za lečenje odloženog napada emezisa
AU7037591A (en) Stabilization of t-pa pro
ES2106680A1 (es) Composiciones acuosas conteniendo ciprofloxacino y utilizacion y procedimiento correspondiente.
HK1006282A1 (en) Novel liquid compositions based on derivatives of 1, 4 substituted piperidine
MX9703839A (es) Soluciones intravenosas de lubeluzol.
CA2187030A1 (fr) Shampooing anti-pellicules ameliore
IT1263107B (it) Composizioni galeniche a base di calcitonina stabilizzate
UA10825A (uk) Протимікробhий засіб

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100622